1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Venetoclax 100 MG: new trials by email Literature Review of Venetoclax 100 MG trials Research Report on Venetoclax 100 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML Venetoclax 100 MG, Itraconazole capsule, Azacitidine Injection - AML | Phase 2 | Completed | Hospital Universitario Dr. Jose E. Gonzalez | 15 | 2021-07-26 | 2023-01-25 |
| Venetoclax and Irinotecan in Relapsed/Refractory SCLC Venetoclax 50 MG, Venetoclax 100 MG, Venetoclax 200 MG - Relapsed Small Cell Lung Cancer, Refractory Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Withdrawn | Virginia Commonwealth University | 2021-06-30 | 2021-03-03 |
Leukemia, Myeloid, Acute (1) · Small Cell Lung Carcinoma (1)
Hospital Universitario Dr. Jose E. Gonzalez (1) · Virginia Commonwealth University (1)
Mexico (1)
David Gomez-Almaguer (1) · Sosipatros Boikos, MD (1)